Peregrine Announces Opening of a New Study in Hepatic Cancer
(Business Wire)...~~~Radiofrequency ablation will generate tumor necrosis which should serve to augment the binding of Cotara,......Cotara is currently being studied in a multi-center Phase II study for brain cancer.......rather than surface cancer cells, as a means to attack solid tumors, without causing damage to surrounding healthy tissue....- Apr 19 8:09 AM ET
IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://biz.yahoo.com/bw/010419/2124.html
(Everything below this line is from VirtualTrials.com!)
Click HERE to return to brain tumor news headlines